SCHEMBL6471017

SCHEMBL6471017

Cc1ccc(OCCCCn2c(=O)c3cc(C(=O)OCc4ccccc4)sc3n(C)c2=O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 2/20 0.42
ALDH1A1 P00352 5/20 0.41
HSD17B10 Q99714 4/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
TSHR P16473 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HPGD P15428 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KDM4E B2RXH2 5/20 0.40
MAPT P10636 3/20 0.40
LMNA P02545 2/20 0.40
ESR1 P03372 2/20 0.40
ALOX15 P16050 1/20 0.40
GPR55 Q9Y2T6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6261557 0.94 MMP13 (0.41) ALDH1A1HSD17B10NPC1RAB9ATSHR
SCHEMBL6254241 0.92 MMP13 (0.42) ALDH1A1HSD17B10NPC1RAB9ATSHR
SCHEMBL6736477 0.91 KDM4E (0.44) ALDH1A1HSD17B10NPC1RAB9ATSHR
SCHEMBL6260489 0.89 MMP13 (0.42) ALDH1A1HSD17B10NPC1RAB9ATSHR
SCHEMBL6462794 0.87 MMP13 (0.41) ALDH1A1HSD17B10RAB9ATSHRHPGD
SCHEMBL6255416 0.87 MMP13 (0.36) ALDH1A1HSD17B10NPC1RAB9ATSHR
SCHEMBL6470802 0.86 TRPA1 (0.48) ALDH1A1HSD17B10TSHRMEN1KMT2A
SCHEMBL6730276 0.86 MMP13 (0.43) ALDH1A1HSD17B10TSHRMEN1KMT2A
SCHEMBL6259363 0.85 ADORA2B (0.44) ALDH1A1HSD17B10TSHRMEN1KMT2A
SCHEMBL6730298 0.85 MMP13 (0.44) ALDH1A1HSD17B10TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1530475-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 AND A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 Warner-Lambert Company LLC (US) 2005-05-18 EP disclosed
WO-2004006931-A2 PHARMACEUTICAL COMPOSTIONS COMPRISING AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 AND A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 WARNER-LAMBERT COMPANY LLC (US) 2004-01-22 WO disclosed